CompletedEUCTR 2009-018064-95
Amyloid imaging in late life depression
This historical record does not confirm current site availability.
Historical research recordBelgium
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Belgium
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University of Leuven
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Belgium
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2009-018064-95
- Official title
Show the full official title
Amyloid imaging in late life depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedBelgium
Registry details
Historical country statuses
- Belgium — Completed
Questions about this study
Who is behind this study?
The study sponsor is University of Leuven, a university.
Want to explore more studies?
Explore studiesRelated studies
Intranasal Esketamine Added to Standard Care for Adults at Imminent Suicide Risk
A Double-Blind, Double-Randomization, Placebo-Controlled Study of the Efficacy of Intravenous Esketamine in Adult Subjects with Treatment-Resistant Depression